Background-Oxidative stress in the vasculature has been implicated in the pathogenesis of coronary artery disease (CAD).
O xidative stress in the vasculature induced by ⅐O 2 Ϫ has been implicated in the pathogenesis of CAD. 1 The sources of ⅐O 2 Ϫ in the vasculature are diverse and include VSMCs, endothelial cells, and macrophages. Although NADPH oxidase was originally described in phagocytes, it has recently become evident that the NADH/NADPH oxidase system is an important enzymatic origin of ⅐O 2 Ϫ in nonphagocytic cells such as VSMCs and endothelial cells. 2, 3 A recent investigation shows that p22 phox, one of the electron transfer elements of NADPH oxidase in phagocytes, is expressed in VSMCs and is a critical component for ⅐O 2 Ϫ generation in VSMCs. 4 Four types of allelic polymorphisms in the p22 phox gene have been reported. 5, 6 Among them, C242T polymorphism of the p22 phox substitutes histidine-72 by tyrosine located in the potential heme-binding sites, and A640G polymorphism is located in the 3Ј untranslated region. However, the clinical significance of these polymorphisms has never been examined. The present study was designed to investigate whether these polymorphisms were associated with risk of CAD by use of RFLP.
Methods

Subjects
The study population was composed of 201 case patients and 201 control subjects; all subjects enrolled were Japanese. Case patients, who had been admitted to Kobe University Hospital at the age of Յ70 years, were clinically diagnosed as having CAD, and in all case patients, significant coronary artery stenoses (Ͼ75%) were demonstrated by coronary angiography. The control subjects were selected from the inpatients of the hospital and matched with the case patients for sex, and they had not had any symptoms of CAD or peripheral atherosclerotic artery disease documented. Written consent was obtained from every patient after a full explanation of the study. The Ethics Committee of Kobe University approved this study.
Patients were considered smokers if their smoking index was Ͼ100. They were considered to have hypertension if they met the criteria of the World Health Organization or had already been treated with antihypertensive drugs. They were considered to have hypercholesterolemia if their fasting total plasma cholesterol level was Ͼ220 mg/dL or they had already been treated with cholesterol-lowering drugs. They were defined as having diabetes if they met the diagnostic criteria of the World Health Organization or were already under treatment for diabetes.
Determination of Polymorphisms of p22 phox by RFLP
C242T Polymorphism
Because the C3 T mutation of the C242T polymorphic site produces the Rsa I digestion site, Rsa I RFLP was used to analyze the polymorphism of the p22 phox gene. The p22 phox gene containing this polymorphic site was amplified from genomic DNA isolated from subjects by PCR. Digestion of the PCR product (348 bp) by Rsa I makes 160-and 188-bp fragments in the C3 T mutation, whereas Rsa I does not cut the PCR product in the wild type.
A640G Polymorphism
The A3 G mutation of this polymorphic site loses the Dra III digestion site. The digestion of the PCR product (258 bp) by Dra III makes 227-and 31-bp fragments in the wild type, whereas Dra III does not cut the PCR product in the A3 G mutation.
The resulting fragments were separated by agarose gel electrophoresis and identified by ethidium bromide staining (Fig) . The results were confirmed by at least two investigators, who did not know the origin of the genomic DNA.
Statistical Analysis
Data on age are presented as meanϮSD, and the difference in age was analyzed by unpaired Student's t test. The differences in frequencies of smoking, hypertension, hypercholesterolemia, diabetes mellitus, and p22 phox genotypes were analyzed by Fisher's exact test. HardyWeinberg equilibrium was assessed by 2 analysis. Multivariate analyses were conducted with multiple logistic regression methods, and an estimation of conditioned relative risk and 95% CI was done.
Results
The characteristics of the subjects are summarized in Table 1 . There was no significant difference in age between the groups. The coronary risk factors examined, ie, smoking, hypercholesterolemia, hypertension, and diabetes, were significantly pronounced in case patients ( Table 1) .
The distribution of genotypes and the frequency of alleles of the polymorphisms of the p22 phox gene are summarized in Table 2A . The allele frequencies in all subjects were obeyed according to Hardy-Weinberg's law. The T allele frequencies of C242T polymorphism in control subjects and case patients were 0.13 and 0.08, respectively, and the prevalence of the TCϩTT genotype was significantly more frequent in control subjects than in CAD patients. Conversely, the allele frequencies of A640G polymorphism were not different between control subjects and case patients. The odds ratio of the TCϩTT versus the CC genotype of the C242T polymorphism between case patients and control subjects was 0.49 (95% CI, 0.28 to 0.87) (Pϭ.015). The association of this polymorphism with CAD was statistically significant and independent of the A640G polymorphism and other risk factors when subjected to logistic regression analysis (Table 2B) .
Discussion
The present study is the first clinical investigation on the significance of polymorphism of the genes related to ⅐O 2 Ϫ production in CAD. We found that the T allele in the C242T polymorphism of the p22 phox gene was significantly more frequent in control subjects than in CAD patients, indicating that the mutation of the potential heme-binding site in the p22 phox gene might have a protective effect on coronary risk.
Two kinds of NADH/NADPH oxidase system have been proposed to exist, ie, phagocytic and vascular NADH/ NADPH oxidase. In contrast to the phagocytic NADPH oxidase, the molecular identity and clinical significance of the vascular NADH/NADPH oxidase system are poorly understood. p22 phox mRNA is expressed in phagocytes as well as nonphagocytic cells, whereas other components are restricted to phagocytic cells and are hardly detectable in nonphagocytic cells. 7, 8 Ushio-Fukai et al 4 demonstrated that stable transfection of a nearly full-length antisense fragment of the p22 phox gene into VSMCs markedly decreased ⅐O 2 Ϫ production, indicating that the p22 phox gene was a critical component of ⅐O 2 Ϫ production in this cell type.
Selected Abbreviations and Acronyms
CAD ϭ coronary artery disease ⅐O 2 Ϫ ϭ superoxide RFLP ϭ restriction fragment length polymorphism VSMC ϭ vascular smooth muscle cell A, Rsa I RFLP of C242T polymorphism. DNA fragment containing C242T polymorphic site of p22 phox gene was amplified from genomic DNA by PCR with sense primer 5Ј-TGCTTGT-GGGTAAACCAAGGCCGGTG-3Ј (F1) and antisense primer 5Ј-AACACTGAGGTAAGTGGGGGTGGCTCCTGT-3Ј (R1), then PCR product was digested with Rsa I. C3 T mutation at nucleotide 242 creates an Rsa I digestion site, which digests 348-bp fragment into 160-and 188-bp fragments. Bottom, Representative of 2% agarose gel electrophoresis on Rsa I RFLP of p22 phox gene. Lane 1, heterozygote of TC; lanes 2 and 3, homozygotes of CC; lane 4, homozygote of TT. B, Dra III RFLP for A640G polymorphism. DNA fragment containing A640G polymorphic site was amplified from genomic DNA by PCR with sense primer 5Ј-AGCAGTGGACGCCCATCGAGCCCAA-3Ј (F2) and antisense primer 5Ј-CGCTGCGTTTATTGCAGGT-GGGTGC-3Ј (R2), then PCR product (258 bp) was digested with Dra III. Dra III digestion of PCR product makes 227-and 31-bp fragments in wild type, whereas Dra III does not cut PCR product in A3 G mutation. Bottom, Representative of 2% agarose gel electrophoresis on Rsa I RFLP of p22 phox gene. Lane 1, homozygote of GG; lane 2, heterozygote of AG; lane 3, homozygote of AA.
Four types of polymorphism of the p22 phox gene are reported, that is, C242T, C549T, G508A, and A640G. The C242T and C549T polymorphisms affect amino acid sequence, whereas the G508A polymorphism does not because of the degeneracy of the genetic code, and the A640G polymorphism is located in the 3Ј untranslated region. p22 phox, a heme-binding protein, contains two histidine residues at amino acids 72 and 94, respectively, 8 and these are the potential heme-binding sites. Because the C242T polymorphism substitutes the histidine-72 to tyrosine residues, this base substitution may have a direct functional role in the association between the C242T polymorphism and coronary risk. It is interesting to speculate that this mutation of the p22 phox gene might modulate the activity and regulation of NADH/NADPH oxidase, which leads to a decrease of oxidative stress in the vasculature, and it might, in turn, reduce susceptibility to CAD.
In conclusion, the prevalence of the TCϩTT genotype of the C242T polymorphism of the p22 phox gene in control subjects was significantly more frequent than that in CAD patients. To confirm that this polymorphism is a novel genetic marker for CAD, investigations in a larger population and other ethnic populations are necessary. Although some antioxidants have been reported to have beneficial effects on CAD, the precise criteria for their use are not fully determined. Some method to distinguish patients who have genetically increased susceptibility to oxidative stress would be a great advantage in treatment for CAD. Genetic investigation of the genes related to oxidative stress, like this study, might provide clues for determination of patients genetically susceptible to oxidative stress. Odds ratios and 95% CIs were calculated by multiple logistic regression analyses. 
